HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo.

AbstractAIM:
To study the immunosuppressive activity of SM735 {[3-(12-beta-artemisininoxy)] phenoxyl succinic acid}, a synthetic artemisinin derivative with nonsteroidal anti-inflammatory drug structure, with the aim of finding potential immunosuppressive agents.
METHODS:
Concanavalin A (ConA), lipopolysaccharide (LPS), and mixed lymphocyte reaction (MLR), were used to induce the proliferation of splenocytes, and [3H]-thymidine incorporation was used to evaluate the proliferation of splenocytes. Cytokine production was promoted with ConA, LPS, or PMA plus ionomycin, and was detected with the enzyme-linked immunosorbent assay. Dinitrofluorobenzene (DNFB) and sheep red blood cells (SRBC) were used to induce delayed-type hypersensitivity and quantitative hemolysis of SRBC (QHS) mouse models, as criteria for the evaluation of in vivo immune activity.
RESULTS:
SM735 strongly inhibited the proliferation of splenocytes induced by ConA, LPS, or MLR, with IC(50) values of 0.33 micromol/L, 0.27 micromol/L, and 0.51 micromol/L, respectively. When compared with a CC(50) value of 53.1 micromol/L, SM735 had a favorable safety range. SM735 dose-dependently inhibited proinflammatory cytokine production [including interleukins (IL)-12, interferon (IFN)-gamma and IL-6] induced by LPS or PMA plus ionomycin. Upon ConA stimulation, SM735 suppressed IFN-gamma in a dose-dependent manner, but did not affect IL-2 secretion. SM735 also strongly suppressed both T-cell-mediated delayed-type hypersensitivity (DTH) and B-cell-mediated QHS reactions.
CONCLUSION:
SM735 had strong immunosuppressive activity in vitro and in vivo, suggesting a potential role for SM735 as an immunosuppressive agent, and established the groundwork for further research on SM735.
AuthorsWen-liang Zhou, Jin-ming Wu, Qing-li Wu, Jun-xia Wang, Yu Zhou, Ru Zhou, Pei-lan He, Xiao-yu Li, Yi-fu Yang, Yu Zhang, Ying Li, Jian-ping Zuo
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 26 Issue 11 Pg. 1352-8 (Nov 2005) ISSN: 1671-4083 [Print] United States
PMID16225758 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 3-(12-beta-artemisininoxy) phenoxyl succinic acid
  • Anti-Inflammatory Agents, Non-Steroidal
  • Artemisinins
  • Cytokines
  • Immunosuppressive Agents
  • Succinates
  • Interleukin-12
  • Interferon-gamma
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (chemistry)
  • Artemisinins (administration & dosage, pharmacology)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Cytokines (metabolism)
  • Dose-Response Relationship, Drug
  • Hemolysis (drug effects)
  • Hypersensitivity, Delayed (chemically induced, prevention & control)
  • Immunosuppressive Agents (administration & dosage, pharmacology)
  • Inhibitory Concentration 50
  • Interferon-gamma (metabolism)
  • Interleukin-12 (metabolism)
  • Lymphocyte Culture Test, Mixed
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Succinates (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: